Hematopoietic growth colony stimulating factors (G-CSF) are recommended in all patients with germ cell tumor (GCT) receiving chemotherapy to diminish the incidence of neutropenia and infection ( 11 , 12 ). This evidence concerns the gene CSF3 and neutropenia.